| BUSINESS STRATEGY |
The ultimate that a generic company can do in terms of innovation is to turn itself into a proprietary company. Co is far along in this direction. "In terms of R&D, we're going forward strictly on the branded side of the business. "We will continue to enjoy the revenue streams from our generic products, but we're not developing any more generic products." |
| OBSERVATION'S |
"A 30-month clock that is consistently applied to all companies levels the playing field between innovator and generic companies. With just one 30-month clock, generic companies can predict with some certainty when they can launch their products, and innovator companies can put in place strategies to extend product life cycles before that clock starts, he explains. "Both sides know exactly what the rules are, and they work within that environment." |
| TECHNOLOGY | oral, once-daily, controlled-release medications. The technological barrier to entry in this segment is significant |
| UPDATE | 09.02 |
| COMPANY | This data is not available for free |
| CONTACT | This data is not available for free |
| LITERATURE REF. | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |